Methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate, 95.0%, 25g

4-BROMO-2-(PYRROLIDIN-1-YL)ANILINE, 95.0%, 500mg

2-Amino-5-(trifluoromethyl)benzamide, 98%, 1g

5-Fluorothiazol-2-amine hydrochloride, 95.0%, 5g

6-G1 2AB (500pmol/vial)1vial

5-BROMO-3-METHOXY-N-METHYLPYRAZIN-2-AMINE, 95%, 100mg

(2R,6R)-2,6-Dimethylmorpholine, 95.0%, 1g

Aluminium foil 99.5% 0.25 x 300 x 300 mm 1 pc

(S)-2-((Tert-butoxycarbonyl)amino)-3-cyclobutylpropanoic acid, 98%, 25g

(1S*,5R*,6S*,7R*)-3-methyl-4-oxo-10-oxa-3-azatricyclo[5.2.1.0~1,5~]dec-8-ene-6-carboxylic acid, 95.0%, 250mg

Methacrylic acid, stabilised with MeHQ, 99.0%, 100g

(E)-2-(4-Fluorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

(6-Bromo-2-fluoropyridin-3-yl)boronic acid, 95.0%, 1g